Evidence map›Paper›PMID 36432028›Full record

ReviewMolecules (Basel, Switzerland)2022

Iridium and Ruthenium Complexes Bearing Perylene Ligands.

Luca Mauri, Alessia Colombo, Claudia Dragonetti, Francesco Fagnani, Dominique Roberto

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luca MauriDipartimento di Chimica, Università di Milano and INSTM UdR Milano, Via Golgi 19, I-20133 Milan, Italy.ORCID 0000-0002-5477-383X
Alessia ColomboDipartimento di Chimica, Università di Milano and INSTM UdR Milano, Via Golgi 19, I-20133 Milan, Italy.ORCID 0000-0001-8004-3200
Claudia DragonettiDipartimento di Chimica, Università di Milano and INSTM UdR Milano, Via Golgi 19, I-20133 Milan, Italy.ORCID 0000-0002-0106-0860
Francesco FagnaniDipartimento di Chimica, Università di Milano and INSTM UdR Milano, Via Golgi 19, I-20133 Milan, Italy.ORCID 0000-0002-3425-6106
Dominique RobertoDipartimento di Chimica, Università di Milano and INSTM UdR Milano, Via Golgi 19, I-20133 Milan, Italy.ORCID 0000-0001-9659-4760

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present review summarizes the work carried out mostly in the last decade on iridium and ruthenium complexes bearing various perylene ligands, of particular interest for bioimaging, photodynamic therapy, and solar energy conversion. In these complexes, the absorption spectra and the electrochemical properties are those of the perylene subunit plus those of the metal moiety. In contrast, the emissions are completely changed with respect to perylenes considered alone. Thus, fully organic perylenes are characterized by a strong fluorescence in the visible region, lifetimes of a few nanoseconds, and luminescence quantum yields approaching 100%, whereas perylene Ir and Ru complexes usually do not emit; however, in few cases, weak phosphorescent emissions, with lifetimes in the range of microseconds and relatively low quantum yields, are reported. This is due to a strong interaction between the perylene core and the heavy metal center, taking place after the excitation. Nevertheless, an important advantage deriving from the presence of the heavy metal center is represented by the ability to generate large amounts of singlet oxygen, which plays a key role in photodynamic therapy.

Indexed as

PeryleneRutheniumIridiumLigandsLuminescenceIridiumLigandsPeryleneRutheniumabsorption propertiesemission propertiesiridiumperylenephotodynamic therapyrutheniumsinglet oxygen

Identifiers

PMID36432028
PMCPMC9697229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.